SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF

SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

Exercise

(1)01/16/2024

Common Stock, $0.01 Par

Value Per Share

Common Stock, $0.01 Par

  • Incentive Stock Option (Right to Buy) 04/16/202004/16/2025

    Common Stock, $0.01 Par

    Value Per Share

  • Incentive Stock Option (Right to Buy) 10/15/202010/15/2025

    Common Stock, $0.01 Par

    Value Per Share

  • Incentive Stock Option (Right to Buy) 04/20/202104/20/2026

    Common Stock, $0.01 Par

    Value Per Share

  • Incentive Stock Option (Right to Buy) 01/19/202201/19/2027

    Common Stock, $0.01 Par

    Value Per Share

  • Non-Qualified Stock Option (Right to Buy) 01/21/201501/21/2020

Value Per Share

5,630

1,000

1,241

1,144

1,200

(2)01/20/2021

(3)01/19/2022

(4)04/18/2023

(5)01/16/2024

Common Stock, $0.01 Par

Value Per Share

Common Stock, $0.01 Par

Value Per Share

Common Stock, $0.01 Par

Value Per Share

Common Stock, $0.01 Par

Value Per Share

(6)04/16/2025

(7)10/15/2025

Common Stock, $0.01 Par

Value Per Share

5,000

4,000

5,000

2,370

4,000

Common Stock, $0.01 Par

Value Per Share

9,890

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

Exercise

(8)04/20/2026

Common Stock, $0.01 Par

Value Per Share

18,759

(9)01/19/2027

Common Stock, $0.01 Par

23,856

Value Per Share

(10)01/17/2028

Common Stock, $0.01 Par

11,490

Value Per Share

(11)01/16/2029

Common Stock, $0.01 Par

25,810

Value Per Share

(12) (12)

Common Stock, $0.01 Par

6,200

Value Per Share

(14) (14)

Common Stock, $0.01 Par

4,210

Value Per Share

(15) (15)

Common Stock, $0.01 Par

Value Per Share

6,720

Explanation of Responses:

  • 1. This option became exercisable in five equal annual installments beginning January 16, 2015, of 1,126 shares.

  • 2. This option became exercisable in five equal annual installments beginning January 20, 2012, of 1,000 shares.

  • 3. This option exercisable in five equal annual installments beginning January 19, 2013, of 800 shares.

  • 4. This option became exercisable in five equal annual installments beginning April 18, 2014, of 1,000 shares.

  • 5. This option became exercisable in five equal annual installments beginning January 16, 2015, of 474 shares.

  • 6. This option became exercisable in three equal annual installments beginning April 16, 2016, of 1,000 shares and becomes exercisable in a final installment of 1,000 shares on April 16, 2019.

  • 7. This option became exercisable in four equal annual installments of 2,000 shares beginning October 15, 2016, and a final installment of 1,890 shares on October 15, 2020.

  • 8. This option became exercisable in four equal annual installments of 4,000 shares beginning April 20, 2017, and a final installment of 2,759 shares on April 20, 2021.

  • 9. This option became exercisable in four equal annual installments of 5,000 shares beginning January 19, 2018, and a final installment of 3,856 shares on January 19, 2022.

  • 10. This option became exercisable in five equal annual installments of 2,298 shares beginning January 17, 2019.

  • 11. This option becomes exercisable in five annual installments of 5,162 shares beginning January 16, 2020.

  • 12. The restricted stock unit award was granted on January 19, 2017 and vests 100% on January 19, 2020.

  • 13. Each restricted stock unit represents the right to receive, at settlement, one (1) share of common stock.

  • 14. The restricted stock unit award was granted on January 17, 2018 and vests 100% on January 17, 2021.

  • 15. The restricted stock unit award was granted on January 16, 2019 and vests 100% on January 16, 2022.

02/19/2019

/s/ Grace B. Holmes, Attorney-in-Fact Date

** Signature of Reporting Person

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

SCHLUMBERGER LIMITED POWER OF ATTORNEY

The undersigned, in his capacity as a director or officer, or both, of Schlumberger Limited, a Curacao corporation (the "Company"), does hereby appoint each of Saul Laureles, Matthew Rinegar and Grace Holmes, or any of them acting singly, his true and lawful attorney-in-fact with full power of substitution, to (a) prepare, execute in the undersigneds name and on the undersigneds behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes, passwords and passphrases enabling theundersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended (the Exchange Act), or any rule or regulation of the SEC; and (b) execute for and on behalf of the undersigned, in the undersigneds capacity as a director or officer, or both, of the Company, Forms 3, 4 and 5 in accordance with Section 16 of the Exchange Act, as well as Forms 144, and complete and execute any amendment or amendments thereto, and to file the same or cause the same to be filed with the SEC.

This Power of Attorney supersedes any and all prior and existing powers of attorney signed by the undersigned with respect to the subject matter hereof, and shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, 5 or 144 with respect to the undersigneds holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

February 8, 2019

/s/ Gavin Rennick Gavin Rennick

Attachments

  • Original document
  • Permalink

Disclaimer

Schlumberger Ltd. published this content on 19 February 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 19 February 2019 19:28:06 UTC